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Abstract
Background: Radiofrequency catheter ablation of atrial fibrillation (AF) has been proved to be effective and to
prevent progressive left atrial (LA) remodeling. Cryoballoon catheter ablation (CCA), using a different energy source,
was developed to simplify the ablation procedure. Our hypothesis was that successful CCA can also prevent
progressive LA remodeling.
Methods: 36 patients selected for their first CCA because of nonvalvular paroxysmal AF had echocardiography
before and 3, 6 and 12 months after CCA. LA diameters, volumes (LAV) and LA volume index (LAVI) were
evaluated. LA function was assessed by: early diastolic velocities of the mitral annulus (Aasept,A a lat), LA filling
fraction (LAFF), LA emptying fraction (LAEF) and the systolic fraction of pulmonary venous flow (PVSF). Detailed left
ventricular diastolic function assessment was also performed.
Results: Excluding recurrences in the first 3-month blanking period, the clinical success rate was 64%. During one-
year of follow-up, recurrent atrial arrhythmia was found in 21 patients (58%). In the recurrent group at 12 months
after ablation, minimal LAV (38 ± 19 to 44 ± 20 ml; p < 0.05), maximal LAV (73 ± 23 to 81 ± 24 ml; p < 0.05), LAVI
(35 ± 10 to 39 ± 11 ml/m
2; p = 0.01) and the maximal LA longitudinal diameter (55 ± 5 to 59 ± 6 mm; p < 0.01)
had all increased. PVSF (58 ± 9 to 50 ± 10%; p = 0.01) and LAFF (36 ± 7 to 33 ± 8%; p = 0.03) had decreased. In
contrast, after successful cryoballoon ablation LA size had not increased and LA function had not declined. In the
recurrent group LAEF was significantly lower at baseline and at follow-up visits.
Conclusions: In patients whose paroxysmal atrial fibrillation recurred within one year after cryoballoon catheter
ablation left atrial size had increased and left atrial function had declined. In contrast, successful cryoballoon
catheter ablation prevented progressive left atrial remodeling.
Keywords: Paroxysmal atrial fibrillation, Cryoballoon catheter ablation, Echocardiography, Left atrial remodeling,
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Background
The relationship between left atrial (LA) dilatation and
atrial fibrillation (AF) has been widely accepted for a
long time [1]. Electrophysiological, structural and func-
tional atrial remodeling have been observed in patients
with AF, and it has been shown that normal myocardial
tissue is often replaced with fibrosis [2]. Dilated left
atrium predict later cardiovascular events [3]. Catheter
ablation of atrial fibrillation has been established as a
therapeutic option for patients with symptomatic, drug-
resistant AF [4,5].
Radiofrequency catheter ablation (RFCA) can affect
left atrial size and function either from the scar caused
by the ablation or from reverse atrial remodeling follow-
ing conversion to normal sinus rhythm. After successful
RFCA of atrial fibrillation, LA size has been found to
decrease and LA function and left ventricular diastolic
function to improve; the process has been called ‘reverse
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any medium, provided the original work is properly cited.LA remodeling’. In contrast, after an unsuccessful cathe-
ter ablation, opposite changes were observed [6-13] and
confirmed by a meta-analysis [14].
Cryothermal energy is an alternative energy source
that has been developed to overcome some of the disad-
vantages of RFCA. Cryoenergy offers increased catheter
stability, less endothelial disruption with lower throm-
boembolic risk, and minimal tissue contraction with
healing, less generation of inhomogeneous lesions, less
oesophageal damage and fewer pulmonary vein stenoses.
Balloon-based cryo-technology potentially offers a sim-
pler and faster means of isolating the pulmonary veins
that, theoretically, relies less on the dexterity of the
operator and causes less scar in the left atrium. Previous
studies suggest this is a safe and feasible approach with
a similar success rate in patients with paroxysmal AF
(PAF) to radiofrequency catheter ablation [15].
Left atrial remodeling has not been examined in the
previous studies which used cryoballoon catheter abla-
tion of patients with AF [15,16]. Our hypothesis was
that successful cryoballoon catheter ablation of patients
with paroxysmal AF similarly to RFCA can also prevent
progressive LA remodeling.
Methods
Patients
36 consecutive patients with recurrent, symptomatic,
nonvalvular PAF were enrolled in the study between
June 2008 and July 2009. All had failed to respond anti-
arrhythmic (propafenone, or amiodarone, or sotalol) or
beta blocker therapy. They underwent their first catheter
ablation by the cryoballoon technique.
The study was carried out in compliance with the Hel-
sinki Declaration and was approved by the Regional and
Institutional Scientific and Research Ethics Committee
of the Semmelweis University Budapest (reference num-
ber: TUKEB 70/2008). All patients gave written
informed consent before participating in the study.
Cryoballoon ablation
As described in our previous report [17], all patients were
treated with a double lumen cryoballoon (Arctic front,
Cryocath, Montreal, Quebec), after local anaesthesia and
under conscious sedation using boluses of midazolam
and fentanyl. At first a decapolar electrophysiological
catheter (Bard Electrophysiology Inc., Lowell, MA, USA)
was placed in the coronary sinus through the right jugu-
lar vein, and a diagnostic quadripolar electrophysiological
catheter was introduced through the right femoral vein
and positioned in the right ventricle. An intracardiac
echocardiography catheter (Acunave, Acuson, Mountain
View, CA, USA) was introduced through the left femoral
vein and positioned in the right atrium, in order to
ensure safe transseptal approach. After the intracardiac
echocardiography-guided single posterior transseptal
puncture, a circular mapping catheter (Lasso catheter,
PV Orbiter, Bard) was advanced and positioned in the
antrum of each pulmonary vein to record the presence of
pulmonary vein potentials. After registration, the 8 F
sheath was exchanged for a 14 F steerable sheath, and
the mapping catheter was exchanged for a 28 mm bal-
loon catheter and positioned over an exchange wire to
occlude the ostium of each pulmonary vein. At least two
5-minute cryo applications per vein were given to each
vein, during using continuous phrenic nerve stimulation
when freezing the ostium of the right superior pulmonary
vein.
Study protocol
Antiarrhythmic drugs were stopped 5 half-lives before
the ablation, and were not continued afterwards. Oral
anticoagulation was before and after ablation, according
to the CHADS2-score based on the valid guideline [18].
Comprehensive transthoracic echocardiographic exam-
inations were performed in all patients during sinus
rhythm before, and 3, 6 and 12 months after cryoballoon
catheter ablation. Transoesophageal echocardiography
was performed in all patients before catheter ablation, to
exclude left atrial and left atrial appendage thrombus.
Transthoracic and transoesophageal echocardiography
were performed within 24 hours of each other.
After the ablation, follow-up examinations at 1, 3, 6
and 12 months included clinical history and examina-
tion, ECG and 24-hour Holter ECG. A 10-day transtele-
phonic ECG was performed before the 3-month, 6-
month and 12-month follow-up visits.
Definition of success
Based on the definition of the Expert Consensus State-
ment on Catheter and Surgical Ablation of Atrial Fibril-
lation [4], cryoballoon catheter ablation was considered
to be clinically successful, if after the initial 3-month
blanking period–a time interval during which success is
not evaluated–recurrent atrial arrhythmia was not
recognized on clinical, or ECG or Holter ECG, or trans-
telephonic ECG examinations.
In order to evaluate the effect of all episodes of recur-
rent arrhythmia, recurrences in the blanking period
were also taken into account for the final analysis. So
the patients were divided into recurrent and arrhythmia-
free (AF-free) groups. The recurrent group was defined
as patients with recurrent atrial arrhythmia at any time
during the follow-up.
Echocardiography
Transthoracic echocardiography was performed with a
General Electric Vivid S6 machine (General Electric,
Milwaukee, WI, USA).
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Page 2 of 10Left ventricular (LV) global systolic function was
assessed by ejection fraction (EF) evaluated by the modi-
fied biplane Simpson’s rule. LV longitudinal systolic
function was assessed by septal and lateral systolic velo-
cities of the mitral annulus (Sasept,S a lat)u s i n gp u l s e d -
wave tissue Doppler echocardiography (TDE).
In order to evaluate LA remodeling LA size and LA
function were evaluated before and after ablation. LA
volumes were calculated by two-dimensional echocar-
diography by the biplane area-length method. Maximal
LA volume (LAVmax) was obtained at left ventricular
end-systole, just before mitral valve opening. Minimal
LA volume (LAVmin) was determined at left ventricular
end-diastole. LA areas (A1,A 2) and superoinferior longi-
tudinal diameters were measured from apical 4- and 2-
chamber views. LA volumes were calculated by the fol-
lowing formula [19]: LAV = 8/3π*A1*A2/L =
0.85*A1*A2/L, where L is the shorter superoinferior dia-
meter of the LA. LA volume index (LAVI) was calcu-
lated by dividing maximal LA volume by the body
surface area (calculated by the Dubois formula, using
body height and weight).
The evaluation of LA function by echocardiography is
not standardized; different methods have been used to
assess LA function in research and in clinical practice
[20,21]. The left atrium serves multiple functions, acts
as a reservoir during left ventricular systole; as a conduit
for blood transiting from the pulmonary veins to the LV
during early diastole and as an active contractile pump
that augments LV ventricular filling in late diastole.
In the present study four TTE methods were used in
the assessment of LA function.
LA booster pump (contractile) function was assessed
by:
a) the LA filling fraction (LAFF) which is the ratio of
the velocity time integral (VTI) of the late diastolic A
wave velocity of mitral inflow to the VTI of the early
and late diastolic velocities of mitral inflow (LAFF =
VTIA/VTIE+A) and
b) septal and lateral velocities of the mitral annulus
during atrial contraction (Aasept,A a lat), measured by
pulsed-wave TDE.
LA reservoir function was assessed by:
a) LA total emptying fraction (LAEF = (LAVmax-LAV-
min)/LAVmax) and
b )t h es y s t o l i cf r a c t i o no fp u l m o n a r yv e n o u sf l o w
(PVSF = VTIS/VTIS+D). Pulmonary venous flow was
measured within right upper pulmonary vein.
More recent methods of evaluating LA function, such
as colour-coded tissue-Doppler based strain and strain-
rate and two-dimensional speckle-tracking based strain
and strain rate were not available in our institute during
the study period.
In the detailed evaluation of left ventricular diastolic
dysfunction, we used the methods described in recent
recommendations [22,23]. Septal and lateral early diasto-
lic velocities of the mitral annulus (Easept,E a lat)w e r e
measured by TDE, which characterize left ventricular
relaxation. In the assessment of mean left ventricular
filling pressure E/Ea ratios were calculated, using both
the lateral, septal and average Ea velocity. Early (E) and
late diastolic (A) velocities of mitral inflow, and decel-
eration time (DT) were measured by pulsed wave Dop-
pler echocardiography, and E/A ratio was calculated.
Systolic (S) and diastolic (D) velocities of pulmonary
venous flow were measured and S/D ratio was also
calculated.
Statistical analysis
Data are shown as mean ± standard deviation (SD) (95%
confidence interval). Unpaired t-test was used to com-
pare means of continuous variables between unrelated
groups. Chi-square analysis was used to compare patient
group characteristics with discrete variables. Paired-sam-
ple Student’s t-test was used to evaluate changes in
echocardiographic parameters of LA size and function
and of LV diastolic function during the follow-up period
within groups. A p < 0.05 was considered statistically
significant for all calculations. Statistical analysis was
performed using SPSS (Statistical Software for Social
Sciences) version 13.0.
Results and discussion
Procedural outcome
The clinical success rate, as it was defined previously
with no recurrence after the 3-month blanking period
[4], was 23 out of 36 patients (64%). Repeat ablation had
not been performed during the first year follow-up.
15 patients were totally free of arrhythmias through-
out the first 12 months of follow-up (the AF-free
group). The other 21 patients (the recurrent group)
experienced some recurrence of atrial arrhythmias. Only
early (within 3 months after treatment) recurrence in 8,
only between 3 and 12 months after treatment recur-
rence in 4, both early and 3 to 12 months recurrences
in 9 patients were detected.
Baseline characteristics
Baseline clinical characteristics
36 consecutive patients were enrolled in the study; there
were 26 males and the mean age was 57.4 ± 8.9 years.
The most frequent symptom was palpitation; signs or
symptoms of congestive heart failure were not present.
27 patients (75%) had hypertension. The average time
period from the first recognition of AF was 6.7 ± 7.3
years (range 0.5-20).
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rent group), had a longer duration of atrial fibrillation
(8.8 ± 8.7 vs 3.8 ± 3.3 years, p < 0.05) before cryobal-
loon catheter ablation. At baseline, patients’ age, gender,
prevalence of concomitant diseases such as hyperten-
sion, diabetes mellitus, hyperlipidemia and obesity were
not significantly different between the recurrent and
AF-free groups (Table 1).
Baseline echocardiographic characteristics
Left ventricular EF was 63 ± 5% (55-72%). Left ventricu-
lar and left atrial dimensions, and left atrial functional
parameters, TDE parameters of LV diastolic dysfunction
and normal values from the literature [19,23-25] are
shown in Table 1.
Septal and lateral early diastolic velocities of the mitral
annulus (Easept, Ealat), E/Ea ratios, LA size and LA
Table 1 Baseline clinical and echocardiographic characteristics
Total study population (n
= 36)
Recurrent group (n =
21)
AF-free group (n =
15)
Normal values from the
literature
Reference
number
Clinical characteristics
Age (yrs) 57.4 ± 8.9 59.6 ± 5.8 54.2 ± 11.5 - -
Duration of AF
(yrs)
6.7 ± 7.3 8.8 ± 8.7 3.8 ± 3.3* - -
Male (%) 26 (72%) 13 (62%) 13 (87%) - -
Hypertension
(%)
27 (75%) 15 (71%) 12 (80%) - -
Obesity (%) 10 (28%) 3 (14%) 7 (47%) - -
Ischaemic HD 4 (11%) 3 (14%) 1 (7%) - -
Echocardiographic characteristics
LV EF (%) 63 ± 5 64 ± 5 62 ± 6 ≥ 55% [19]
LAVmax (ml) 71 ± 21 73 ± 23 67 ± 20 < 56 [19]
LAVI (ml/m
2) 34 ± 10 35 ± 10 33 ± 9 < 29 [19]
LAVmin (ml) 36 ± 17 38+19 30 ± 12 25 ± 13 [24]
LA SI diam
(mm)
55 ± 5 55 ± 5 54 ± 6 - -
LAEF (%) 51 ± 10 48 ± 11 55 ± 8* 56 ± 8 [24]
LAFF (%) 35 ± 7 36 ± 7 34 ± 7 41 ± 14 [24]
PVSF (%) 59 ± 8 58 ± 9 60 ± 7 60 ± 9 [25]
Aalat (cm/s) 10.1 ± 2.3 9.7 ± 2 10.7 ± 2.7 - -
Aasept (cm/s) 9.1 ± 2 8.8 ± 1.8 9.7 ± 2.1 - -
Ealat (cm/s) 11.1 ± 2.8 11.2 ± 2.4 10.9 ± 3.2 > 10 [23]
Easept (cm/s) 8.4 ± 2.3 8.1 ± 1.9 8.8 ± 2.8 > 8 [23]
E/Eaavg 7.3 ± 2 7.2 ± 1.8 7.3 ± 2.1 < 8 [23]
*: p < 0.05, recurrent vs AF-free group
Abbreviations:
Aalat; late diastolic velocity measured by pulsed-wave tissue Doppler echocardiography at the lateral mitral annulus
Aasept; late diastolic velocity measured by pulsed-wave tissue Doppler echocardiography at the septal mitral annulus
AF; atrial fibrillation
E; early diastolic velocity of mitral pulsed wave Doppler inflow
Eaavg; average value of septal and lateral early diastolic velocities measured by pulsed-wave tissue Doppler echocardiography
Ealat; early diastolic velocity measured by pulsed-wave tissue Doppler echocardiography at the lateral mitral annulus
Easept; early diastolic velocity measured by pulsed-wave tissue Doppler echocardiography at the septal mitral annulus
EF; ejection fraction HD; heart disease
LAEF; left atrial total emptying fraction
LAFF; left atrial filling fraction
LAV; left atrial volume
LAVI; left atrial volume index
LAVmax; left atrial maximal volume
LAVmin; left atrial minimal volume
LV; left ventricular
PVSF; systolic fraction of pulmonary venous flow
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the recurrent and AF-free groups. However, the left
atrial reservoir function by left atrial total emptying frac-
tion was significantly lower in the recurrent group (55 ±
8 vs 48 ± 11%, p < 0.05) (Table 1).
Follow-up results
Left atrial size
In the recurrent group, at 12 months after ablation, the
minimal left atrial volume (38 ± 19 to 44 ± 20 ml; p <
0.05), the maximal left atrial volume (73 ± 23 to 81 ±
24 ml; p < 0.05), LAVI (35 ± 10 to 39 ± 11 ml/m
2; p =
0.01) and the maximal left atrial longitudinal diameter
( 5 5±5t o5 9±6m m ;p < 0.01) had all increased (Fig-
ure 1). In contrast, after successful cryoballoon ablation,
LA size had not increased (Table 2).
Left atrial function
In the recurrent group, at 12 months after ablation, the
left atrial reservoir function as assessed by the systolic
fraction of pulmonary venous flow (58 ± 9 to 50 ± 10%;
p = 0.01) and LA pump function assessed by left atrial
filling fraction (36 ± 7 to 33 ± 8%; p =0 . 0 3 )h a d
decreased (Figure 2). Left atrial total emptying fraction,
which is a parameter of LA reservoir function, did not
change significantly during the follow-up; however, it
was significantly lower at all follow-up visits in the
recurrent group (Figure 3).
In contrast, after successful cryoballoon ablation, LA
function had not declined (Table 2).
Left ventricular diastolic function
Lateral and septal early diastolic velocities did not
change significantly during the follow-up (Table 2).
Whereas, E/Eaaverage, which was used to assess the
mean LV filling pressure, was increased at one year
from baseline values (7.2 ± 1.8 to 8.5 ± 2.3; p = 0.005)
(Figure 4).
Discussion
Our study was the first in which left atrial structural and
functional remodeling were examined in detail in
patients who had cryoballoon catheter ablation for par-
oxysmal atrial fibrillation. Successful ablation prevented
progressive LA remodeling, whereas the left atrium
enlarged in patients with recurrent atrial arrhythmias.
Left atrial size before ablation
In the present study, left atrial size before cryoballoon
ablation did not affect the success rate; there was no dif-
ference in LA size before ablation between AF- free and
recurrent group of patients. These results are similar to
a study by Rodrigues et al. [26] in which PAF patients
underwent radiofrequency catheter ablation and the LA
volume before ablation was not different between the
successful and unsuccessful groups. However, in some
other studies LA enlargement before treatment, detected
by different imaging modalities has been identified as a
risk factor for AF recurrence after radiofrequency cathe-
ter ablation [13,27-30].
Figure 1 Changes in left atrial dimensions and volumes after cryoballoon ablation.( * :p < 0.05, baseline to 12 months; **: p < 0.01,
baseline to 12 months; SD values are in Table 2. LAVmax: left atrial maximal volume, LAVmin: left atrial minimal volume, LAVI: left atrial volume
index, LADmax: maximal longitudinal superoinferior diameter).
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We found that at one year after unsuccessful cryobal-
loon catheter ablation left atrial size had increased. In
contrast, successful ablation had prevented progressive
LA dilatation. The meta-analysis of 17 studies by Jeeva-
nantham et al. [14] confirmed that in patients who had
successful radiofrequency catheter ablation of paroxys-
mal and/or persistent atrial fibrillation LA diameter and
volume decreased, which is described as LA structural
reverse remodeling. After unsuccessful ablation, LA size
did not change or non-significantly increased.
In patients with PAF, LA structural reverse remodel-
ing has not always been observed even after successful
catheter ablation. Beukema et al. [8] found that at six
months left atrial anteroposterior and superoinferior
diameters had decreased in patients who remained in
sinus rhythm. Donal et al. [31] investigated 31 lone PAF
patients after successful RF ablation, and at 1 year also
Table 2 Follow-up results
Recurrent AF-free
Baseline 3 6 12 Baseline 3 6 12
LAVmin (ml) 38 ± 19 41 ± 16 43 ± 18 44 ± 20
a 30 ± 12 32 ± 13 30 ± 11 32 ± 11
LAVmax (ml) 73 ± 23 78 ± 29 78 ± 23 81 ± 24
a 67 ± 20 70 ± 20 67 ± 19 69 ± 15
LAVI (ml/m
2) 35 ± 10 38 ± 13 38+10 39 ± 11
a 33 ± 9 35 ± 8 33 ± 8 34 ± 7
LADmax (mm) 55 ± 5 56 ± 6 58 ± 6 59 ± 6
b 54 ± 6 55 ± 5 56 ± 4 56 ± 5
LAFF (%) 36 ± 7 35 ± 8 34 ± 6 33 ± 8
a 34 ± 7 35 ± 11 38+11 32 ± 8
Aasept (cm/s) 8.8 ± 1.8 8.3 ± 2.1 8.6 ± 1.8 8.8 ± 2.2 9.7 ± 2.1 10.3 ± 3.1
c 10.4 ± 1.7
c 9.7 ± 2.1
Aalat (cm/s) 9.8 ± 2.1 10.1 ± 3.4 10.2 ± 2.7 10.2 ± 2.7 10.7 ± 2.7 10.7 ± 2.2 11.5 ± 2.1 10.8 ± 3.1
LAEF (%) 48 ± 11 47 ± 13 45 ± 10 47 ± 11 55 ± 8
c 55 ± 8
c 56 ± 8
d 55 ± 9
c
PVSF (%) 58 ± 9 55 ± 8 55 ± 9 50 ± 10
a 60 ± 7 56 ± 9 61 ± 9 60 ± 10
Easept (cm/s) 8.1 ± 1.9 8.8 ± 1.6 8.9 ± 1.9 7.7 ± 1 8.8 ± 2.8 9 ± 2.5 8.6 ± 2.3 8.8 ± 2.3
Ealat (cm/s) 11.2 ± 2.4 12 ± 2.5 12 ± 2.8 11.3 ± 1.6 10.9 ± 3.2 11.6 ± 3.5 11.6 ± 3.6 11.7 ± 3.1
E/Eaavg 7.2 ± 1.8 7.3 ± 2. 8 ± 2.6 8.5 ± 2.3
b 7.3 ± 2.1 7.4 ± 2 7 ± 1.5 7.4 ± 2.4
a: p < 0.05, baseline to 12 months;
b: p < 0.01, baseline to 12 months;
c: p < 0.05, recurrent vs AF-free at the same follow-up visit;
d: p < 0.01, recurrent vs AF-free at the same follow-up visit.
Abbreviations:
Aalat; late diastolic velocity measured by pulsed-wave tissue Doppler echocardiography at the lateral mitral annulus
Aasept; late diastolic velocity measured by pulsed-wave tissue Doppler echocardiography at the septal mitral annulus
E; early diastolic velocity of mitral pulsed wave Doppler inflow
Eaavg; average value of septal and lateral early diastolic velocities measured by pulsed-wave tissue Doppler echocardiography
Ealat; early diastolic velocity measured by pulsed-wave tissue Doppler echocardiography at the lateral mitral annulus
Easept; early diastolic velocity measured by pulsed-wave tissue Doppler echocardiography at the septal mitral annulus
LADmax; maximal left atrial longitudinal diameter
LAEF; left atrial total emptying fraction
LAFF; left atrial filling fraction
LAVI; left atrial volume index
LAVmax; left atrial maximal volume
LAVmin; left atrial minimal volume
PVSF; systolic fraction of pulmonary venous flow
Figure 2 Changes in left atrial pump and reservoir function after cryoballoon ablation. (*: p < 0.05, baseline to 12 months; SD values are
in Table 2. LAFF: left atrial filling fraction; PVSF: systolic fraction of pulmonary venous flow).
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meter and LA volume index. R e a n te ta l .o b s e r v e dt h a t
LA area had decreased in lone PAF patients 11 months
after successful RF ablation; but LA area had also
decreased after unsuccessful ablation [6]. Rodrigues [26]
et al. observed that after radiofrequency catheter abla-
tion of PAF, there was no significant change of the LA
maximal volume 8 ± 2 months after ablation, either in
the successful, or in the unsuccessfully treated groups.
In their study the prevalence of hypertension was 39%.
In our study the high prevalence of associated hyperten-
sion (80%), which is a well-known determinant of left
a t r i a ls i z e ,a n dt h el i m i t e ds a m p l es i z e( A F - f r e eg r o u p :
N = 15), probably contributed to the lack of reverse
remodeling. Another potential explanation could be that
the left atrium of the AF-free patients might have been
remodeled to such an extent during the years in which
they had paroxysmal atrial fibrillation (3.8 ± 3.3 years),
that the one-year follow-up period was not long enough
for significant reverse remodeling which could be
recognised by two-dimensional transthoracic echocar-
diography, especially in such a small sample (AF-free
group: N = 15).
Left atrial functional remodeling
Left atrial booster pump function
In our study the left atrial filling fraction–a parameter of
LA pump function–decreased 12 months after ablation
in the recurrent group. After successful cryoballoon
ablation, LA pump function did not change.
In previous studies, after successful radiofrequency
ablation in patients with paroxysmal and/or persistent
AF, LA pump functional parameters, such as LA filling
fraction [6,11], and TDE derived Aa [32] were found to
improve.
In PAF patients who underwent successful radiofre-
quency catheter ablation, similarly to our study, Aa velo-
cities did not change in a study by Rodrigues et al. 8 ± 2
month after RFCA [26]. In studies by Reant et al. [6,7],
neither Aa velocities, nor LAFF changed 12 months
after successful RFCA. Whereas, Donal et al. found an
increase of Aa velocity one year after successful ablation
[31], in addition to an increase in the more sophisticated
LA pump functional parameter of end-diastolic strain
rate.
Left atrial reservoir function
In our study the left atrial total emptying fraction–a
variable of left atrial reservoir function–was lower at
baseline and during follow-up in the recurrent group,
but it did not change in either group.
After 12 months the pulmonary venous systolic frac-
tion–a parameter of LA reservoir function–decreased in
the recurrent group. After successful cryoballoon abla-
tion, it did not change. In other studies [6,33] as con-
firmed by a meta-analysis [14] LA reservoir function,
assessed by LA total emptying fraction, declined in
patients whose arrhythmia recurred.
In PAF patients who underwent successful radiofre-
quency catheter ablation, left atrial total emptying frac-
tion did not change significantly after 8 months [26] or
one year in another studies [6,7]. However, improving
LA compliance was shown by Donal et al. a year after
successful ablation by increasing LA lateral strain and
systolic strain rate [31].
Left ventricular diastolic function before and after
ablation
Left ventricular diastolic function did not affect the suc-
cess rate in the present study; no difference was found
between the groups regarding LV diastolic function at
baseline.
We did not demonstrate any change in Ea velocities
during the one-year follow-up in the recurrent, or in the
AF-free group, similarly to the study of patients with
Figure 3 Left atrial total emptying fraction (LAEF) during the
follow-up.( †: p < 0.05, recurrent vs AF-free at the same follow-up
visit; ††: p < 0.01, recurrent vs AF-free at the same follow-up visit;
SD values are in Table 2).
Figure 4 E/Ea average during the follow-up. (**: p < 0.01,
baseline to 12 months; SD values are in Table 2).
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in the studies by Reant et al. [6,7] Ea was found to
increase following successful radiofrequency catheter
ablation in PAF patients during a 11-month follow-up.
In our study the E/Eaaverage was increased at one
year after cryoballoon catheter ablation in the recurrent
group. E/Ea ratio was shown to decrease [6,7] or did not
change [31] in other studies after successful radiofre-
quency catheter ablation in PAF patients
Limitations
The number of patients in our study was relatively
small, similar to other studies of this topic [6,7,26]; but
we studied a very homogeneous population of patients
with exclusively paroxysmal, nonvalvular atrial fibrilla-
tion and with normal left ventricular ejection fraction.
The post-procedure monitoring of AF recurrences was
fairly intensive in our present study; but it may have
missed asymptomatic recurrences.
We used 2DE to calculate LAV, while measurements
with magnetic resonance imaging (MRI) or multislice
computerized tomography (CT) are more accurate: all
echocardiographic methods systematically underestimate
LAV [34,35]. However, acquisition of MRI images is
time consuming, and the use of multislice CT requires
contrast agents and high radiation exposure. In addition,
follow-up studies with MRI or CT would be very costly.
2DE methods are safe, widely available, inexpensive, fea-
sible and reliable both for research purposes and clinical
practice, especially during follow-up [36]. During long-
term monitoring of left atrial remodelling, echocardio-
graphy might be useful to detect the chronic conse-
quences of both symptomatic and silent recurrent atrial
arrhythmias.
Several approaches are used to measure LAV by 2DE,
which makes the comparison of our data with other stu-
dies more challenging. LA volumes measured in our
s t u d ys e e m e dt ob el a r g e rt h a ns o m eo t h e rs t u d i e s
[37,38], which perhaps influenced the success rate dur-
ing follow-up which was the bottom of the normal
range known from the literature [15].
Usually, 20 to 30% of the patients with clinically
unsuccessful ablation undergo a redo procedure.
According to the definition of the Ablation Consensus
Statement [4] in our study only those 13 patients were
clinically unsuccessful who had recurrent arrhythmia
after the first 3-month blanking period. In that group
during the one-year follow-up period there was no redo
ablation, mainly because of the limited availability and
costs of the procedure. After the one-year follow-up
period, 5 out of the 13 unsuccessful patients (38%)
underwent a repeat ablation procedure (by radiofre-
quency catheter ablation).
Conclusions
In patients whose nonvalvular paroxysmal atrial fibrilla-
tion recurred within one year after cryoballoon catheter
ablation, left atrial size increased, left atrial pump and
reservoir function declined, and the left ventricular fill-
ing pressure increased, all related to left atrial remodel-
ing (progressive enlargement). In contrast, successful
cryoballoon catheter ablation prevented progressive left
atrial remodeling.
It would have been interesting to compare the effect
of cryoballoon catheter ablation and RFCA on the LA
remodeling which can be subject of a further study.
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